The Psychopharmacology Committee of the Royal College of Psychiatrists

Almost a year has passed since I last considered the Psychopharmacology Committee of the Royal College of Psychiatrists. This committee has ten members including the Chair. Here is a summary … Continue reading The Psychopharmacology Committee of the Royal College of Psychiatrists

After the Defeat Depression Campaign

The Defeat Depression Campaign of the 1990s , entirely funded by the pharmaceutical industry, was an “educational campaign” organised by the Royal College of Psychiatrists in association with the Royal … Continue reading After the Defeat Depression Campaign

Soft Power [and telling stories]

This Feature Article made the cover of the BMJ: One of the contributors described an approach to influencing healthcare policy as follows: Telling stories is a well established approach taken … Continue reading Soft Power [and telling stories]

“P R O M I S C U O U S”

29 January 2016, Glasgow, the Royal College of Psychiatrists in Scotland Winter Meeting: “You are either abstinent or promiscuous when it comes to industry (financial links with pharmaceutical companies). Well … Continue reading “P R O M I S C U O U S”

“A wrong un’ when you see it”

The January 2019 edition of the British Journal of Psychiatry has, as its theme: Treatment-Resistant Mood Disorders. In the Journal a “consensus definition” of “treatment resistance” was provided by a … Continue reading “A wrong un’ when you see it”

My formal instruction of resignation as a member of the Royal College of Psychiatrists

Saturday, 24th November 2018 To: The Registrar of the Royal College of Psychiatrists, 21 Prescot St, Whitechapel, London, E1 8BB Dear Dr Adrian James, Resignation as a member of the … Continue reading My formal instruction of resignation as a member of the Royal College of Psychiatrists

The ladder of participation

Yesterday I asked the President of the Royal College of Psychiatrists: “I was wondering when the planned meeting to consider the shared experience of long term antidepressant prescribing, and the … Continue reading The ladder of participation

Med älven

The title of this post comes from a P.S. note in a letter from the Swedish poet Tomas Tranströmer to his American friend Robert Bly. It returned my mind to … Continue reading Med älven

‘A warning to the NHS: don’t let big pharma loose on policy’

What follows are a few extracts from this article in today’s Observer by Chris McGreal:

The Royal Society of Medicine: fine dining but no sunshine

I have written to a number of UK bodies who have a leadership role in healthcare to ask whether they support Sunshine legislation or not? I have now received this response from … Continue reading The Royal Society of Medicine: fine dining but no sunshine

Current education on Schizophrenia and substance misuse

In the public domain, Dr Samei Huda, a British Psychiatrist, has repeatedly stated that it is “propaganda” that the pharmaceutical industry has any significant role in the continuing medical education … Continue reading Current education on Schizophrenia and substance misuse

Room under the umbrella

Minervation Ltd (Mental Elf) has recently shared an analysis and critique of the following paper stating that it was “deeply flawed and unreliable”: The analysis of this paper by Dr … Continue reading Room under the umbrella